SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 274 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $15,000 | +15.4% | 500 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $13,000 | 0.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $13,000 | +30.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $10,000 | -16.7% | 500 | 0.0% | 0.00% | -20.0% |
| Q2 2020 | $12,000 | +33.3% | 500 | 0.0% | 0.01% | +25.0% |
| Q1 2020 | $9,000 | -25.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $12,000 | -14.3% | 500 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $14,000 | -17.6% | 500 | 0.0% | 0.00% | -20.0% |
| Q2 2019 | $17,000 | – | 500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 7,641,250 | $107,207,000 | 7.06% |
| HealthInvest Partners AB | 782,746 | $10,982,000 | 6.50% |
| KOPP INVESTMENT ADVISORS LLC | 729,960 | $10,241,000 | 5.51% |
| Murphy Michael R | 1,028,304 | $14,427,000 | 4.96% |
| Opaleye Management Inc. | 460,000 | $6,454,000 | 3.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 511,244 | $7,173,000 | 1.68% |
| Bruce & Co., Inc. | 394,581 | $5,535,000 | 1.42% |
| AlphaOne Investment Services, LLC | 235,065 | $3,297,000 | 1.40% |
| Ranger Investment Management | 1,560,453 | $21,893,000 | 1.23% |
| NORTHPOINTE CAPITAL LLC | 584,753 | $8,204,000 | 1.07% |